SMARCA4/BRG1 deficiency has been detected in a wide variety of tumors (8–15), such as small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) and thoracic SMARCA4 undifferentiated tumors. Here, SMARCA4 is linked to ovarian small cell carcinoma.